
Our study is out in Cell! Presenting a new way of analyzing gut proteins originating from diet, microbiome, and host. @Elinav_Lab @EranElinav @rvaldesmas authors.elsevier.com/c/1kTSb…

General surgery resident MD-PhD

Our study is out in Cell! Presenting a new way of analyzing gut proteins originating from diet, microbiome, and host. @Elinav_Lab @EranElinav @rvaldesmas authors.elsevier.com/c/1kTSb…

Celebrating the promotion of our friend @Suhaib_K_Abdeen , a warm winter day, and a new generation of wonderful @Elinav_Lab scientists!


On a personal note, doing basic science while also perusing a carrier in general-surgery is extremely challenging and can only be done with the support of family and friends, and I am really grateful for many precious people in life who I cherish @iamstavmoran.

In addition, I want to thank Mr. Morris Khan who supports my science within the "Orion fellowship for outstanding physician-scientists" and colleagues at the @SouraskyMedCtr.

Ghil Jona, Alon Harmelin, Noa Stettner; And our friend from other institutions - Aurelia Saftien, Nyssa Cullin, Koji Atarashi, Jens Puschhof, Minhu Chen, Kenya Honda, Wolfgang Lieb, Corinna Bang, Andre Franke, and Kyanna S. Ouyang.

Shimrit Eliyahu-Miller, Tal Yosef-Hevroni, Liron Richman, Barbara Raykhel, Shira Allswang, and Reut Better; Our friends at the Tel Aviv medical center Niv Zmora, Oren Shibolet, Zamir Halpern, and Nitsan Maharshak. Our friends from WIS Corine Katina, Merav Shmueli, Yishai Levin,

In addition, our friends at the Elinav lab Yotam Cohen, Lara Kern, Yiming He, Fernando Slamovitz, Jotham Suez, Dragos Ciocan, Uria Mor, Mally Dori-Bachash, Shahar Molina, Michal Kori, Yifat Merbl, Suhaib K. Abdeen, Hagit Shapiro and our amazing clinical coordinator team

This work was accomplished by team-work and collaboration of talented hard-working individuals, which I am very grateful to be working with. Specifically, my mentor @EranElinav, my good friends @rvaldesmas and Danping Zang who co-lead this project with me, and Alon Savidor.

Mapping thousands of different gut proteins from diet, microbiome, and host) can be powerful in delineating gut related diseases. Advances in proteomics and artificial intelligence will improve our ability to precisely comprehend the immune and metabolic functions of our guts.

We were also able to identify novel, non-invasive protein biomarkers, for IBD encompassing host and bacterial proteins, advancing the diagnosis and treatment of this horrible condition.

In a series experiments including an interventional dietary study we were also able to identify human subjects’ dietary practices, and non-adherence to medically prescribed diets, for example, a gluten-free diet in newly diagnosed Celiac patients.

We were also able to detemine what are the active bacterial species along the human gastrointestinal tract and whether they express proteins confering antibiotic resistance!

coinciding with over-expression of human antimicrobial peptides.

For example, in several cohorts of subjects suffering from IBD, we observed global suppression of bacterial activity across subjects and species,

Using metagenomics-informed metaproteomics we identifying thousands of bacterial proteins at species level resolution, and defining their current activity.